sales@marketbusinessinsights.com | +1 (518)-300-1070
Market Business Insights Japanese Encephalitis Vaccines Market
Request Sample Buy Now

Table Of Contents 

1 Study Coverage
    1.1 Japanese Encephalitis Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Japanese Encephalitis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Attenuated Vaccines
        1.2.3 Inactivated Vaccines
    1.3 Market by Application
        1.3.1 Global Japanese Encephalitis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adults
        1.3.3 Children
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Japanese Encephalitis Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Japanese Encephalitis Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Japanese Encephalitis Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Japanese Encephalitis Vaccines Sales by Region
        2.4.1 Global Japanese Encephalitis Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Japanese Encephalitis Vaccines by Region (2023-2028)
    2.5 Global Japanese Encephalitis Vaccines Revenue by Region
        2.5.1 Global Japanese Encephalitis Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Japanese Encephalitis Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Japanese Encephalitis Vaccines Sales by Manufacturers
        3.1.1 Global Top Japanese Encephalitis Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Japanese Encephalitis Vaccines in 2021
    3.2 Global Japanese Encephalitis Vaccines Revenue by Manufacturers
        3.2.1 Global Japanese Encephalitis Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Japanese Encephalitis Vaccines Revenue in 2021
    3.3 Global Japanese Encephalitis Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Japanese Encephalitis Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Japanese Encephalitis Vaccines Sales by Type
        4.1.1 Global Japanese Encephalitis Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Japanese Encephalitis Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Japanese Encephalitis Vaccines Revenue by Type
        4.2.1 Global Japanese Encephalitis Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Japanese Encephalitis Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Japanese Encephalitis Vaccines Price by Type
        4.3.1 Global Japanese Encephalitis Vaccines Price by Type (2017-2022)
        4.3.2 Global Japanese Encephalitis Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Japanese Encephalitis Vaccines Sales by Application
        5.1.1 Global Japanese Encephalitis Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Japanese Encephalitis Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Japanese Encephalitis Vaccines Revenue by Application
        5.2.1 Global Japanese Encephalitis Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Japanese Encephalitis Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Japanese Encephalitis Vaccines Price by Application
        5.3.1 Global Japanese Encephalitis Vaccines Price by Application (2017-2022)
        5.3.2 Global Japanese Encephalitis Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Japanese Encephalitis Vaccines Market Size by Type
        6.1.1 North America Japanese Encephalitis Vaccines Sales by Type (2017-2028)
        6.1.2 North America Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
    6.2 North America Japanese Encephalitis Vaccines Market Size by Application
        6.2.1 North America Japanese Encephalitis Vaccines Sales by Application (2017-2028)
        6.2.2 North America Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
    6.3 North America Japanese Encephalitis Vaccines Market Size by Country
        6.3.1 North America Japanese Encephalitis Vaccines Sales by Country (2017-2028)
        6.3.2 North America Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Japanese Encephalitis Vaccines Market Size by Type
        7.1.1 Europe Japanese Encephalitis Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
    7.2 Europe Japanese Encephalitis Vaccines Market Size by Application
        7.2.1 Europe Japanese Encephalitis Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
    7.3 Europe Japanese Encephalitis Vaccines Market Size by Country
        7.3.1 Europe Japanese Encephalitis Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Japanese Encephalitis Vaccines Market Size by Type
        8.1.1 Asia Pacific Japanese Encephalitis Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Japanese Encephalitis Vaccines Market Size by Application
        8.2.1 Asia Pacific Japanese Encephalitis Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Japanese Encephalitis Vaccines Market Size by Region
        8.3.1 Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Japanese Encephalitis Vaccines Market Size by Type
        9.1.1 Latin America Japanese Encephalitis Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Japanese Encephalitis Vaccines Market Size by Application
        9.2.1 Latin America Japanese Encephalitis Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Japanese Encephalitis Vaccines Market Size by Country
        9.3.1 Latin America Japanese Encephalitis Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Type
        10.1.1 Middle East and Africa Japanese Encephalitis Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Application
        10.2.1 Middle East and Africa Japanese Encephalitis Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country
        10.3.1 Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi Pasteur
        11.1.1 Sanofi Pasteur Corporation Information
        11.1.2 Sanofi Pasteur Overview
        11.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Pasteur Recent Developments
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Corporation Information
        11.2.2 GlaxoSmithKline Overview
        11.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GlaxoSmithKline Recent Developments
    11.3 Bharat Biotech
        11.3.1 Bharat Biotech Corporation Information
        11.3.2 Bharat Biotech Overview
        11.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bharat Biotech Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bharat Biotech Recent Developments
    11.4 China National Biotec Group
        11.4.1 China National Biotec Group Corporation Information
        11.4.2 China National Biotec Group Overview
        11.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 China National Biotec Group Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 China National Biotec Group Recent Developments
    11.5 Valneva Products
        11.5.1 Valneva Products Corporation Information
        11.5.2 Valneva Products Overview
        11.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Valneva Products Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Valneva Products Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Japanese Encephalitis Vaccines Industry Chain Analysis
    12.2 Japanese Encephalitis Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Japanese Encephalitis Vaccines Production Mode & Process
    12.4 Japanese Encephalitis Vaccines Sales and Marketing
        12.4.1 Japanese Encephalitis Vaccines Sales Channels
        12.4.2 Japanese Encephalitis Vaccines Distributors
    12.5 Japanese Encephalitis Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Japanese Encephalitis Vaccines Industry Trends
    13.2 Japanese Encephalitis Vaccines Market Drivers
    13.3 Japanese Encephalitis Vaccines Market Challenges
    13.4 Japanese Encephalitis Vaccines Market Restraints
14 Key Findings in The Global Japanese Encephalitis Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Japanese Encephalitis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Attenuated Vaccines
    Table 3. Major Manufacturers of Inactivated Vaccines
    Table 4. Global Japanese Encephalitis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Japanese Encephalitis Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Japanese Encephalitis Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 7. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2017-2022)
    Table 8. Global Japanese Encephalitis Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 9. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2023-2028)
    Table 10. Global Japanese Encephalitis Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2017-2022)
    Table 12. Global Japanese Encephalitis Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2023-2028)
    Table 14. Global Japanese Encephalitis Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
    Table 15. Global Japanese Encephalitis Vaccines Sales Share by Manufacturers (2017-2022)
    Table 16. Global Japanese Encephalitis Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 18. Japanese Encephalitis Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 19. Global Japanese Encephalitis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Japanese Encephalitis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Vaccines as of 2021)
    Table 21. Japanese Encephalitis Vaccines Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Japanese Encephalitis Vaccines Product Offered
    Table 23. Date of Manufacturers Enter into Japanese Encephalitis Vaccines Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Japanese Encephalitis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 26. Global Japanese Encephalitis Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 27. Global Japanese Encephalitis Vaccines Sales Share by Type (2017-2022)
    Table 28. Global Japanese Encephalitis Vaccines Sales Share by Type (2023-2028)
    Table 29. Global Japanese Encephalitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Japanese Encephalitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Japanese Encephalitis Vaccines Revenue Share by Type (2017-2022)
    Table 32. Global Japanese Encephalitis Vaccines Revenue Share by Type (2023-2028)
    Table 33. Japanese Encephalitis Vaccines Price by Type (2017-2022) & (USD/Dose)
    Table 34. Global Japanese Encephalitis Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 35. Global Japanese Encephalitis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 36. Global Japanese Encephalitis Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 37. Global Japanese Encephalitis Vaccines Sales Share by Application (2017-2022)
    Table 38. Global Japanese Encephalitis Vaccines Sales Share by Application (2023-2028)
    Table 39. Global Japanese Encephalitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Japanese Encephalitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Japanese Encephalitis Vaccines Revenue Share by Application (2017-2022)
    Table 42. Global Japanese Encephalitis Vaccines Revenue Share by Application (2023-2028)
    Table 43. Japanese Encephalitis Vaccines Price by Application (2017-2022) & (USD/Dose)
    Table 44. Global Japanese Encephalitis Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 45. North America Japanese Encephalitis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 46. North America Japanese Encephalitis Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 47. North America Japanese Encephalitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Japanese Encephalitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Japanese Encephalitis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 50. North America Japanese Encephalitis Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 51. North America Japanese Encephalitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Japanese Encephalitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Japanese Encephalitis Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 54. North America Japanese Encephalitis Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 55. North America Japanese Encephalitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Japanese Encephalitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Japanese Encephalitis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 58. Europe Japanese Encephalitis Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 59. Europe Japanese Encephalitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Japanese Encephalitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Japanese Encephalitis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 62. Europe Japanese Encephalitis Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 63. Europe Japanese Encephalitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Japanese Encephalitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Japanese Encephalitis Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 66. Europe Japanese Encephalitis Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 67. Europe Japanese Encephalitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Japanese Encephalitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Japanese Encephalitis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 70. Asia Pacific Japanese Encephalitis Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 71. Asia Pacific Japanese Encephalitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Japanese Encephalitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Japanese Encephalitis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 74. Asia Pacific Japanese Encephalitis Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 75. Asia Pacific Japanese Encephalitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Japanese Encephalitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 78. Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 79. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Japanese Encephalitis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 82. Latin America Japanese Encephalitis Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 83. Latin America Japanese Encephalitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Japanese Encephalitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Japanese Encephalitis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 86. Latin America Japanese Encephalitis Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 87. Latin America Japanese Encephalitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Japanese Encephalitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Japanese Encephalitis Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 90. Latin America Japanese Encephalitis Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 91. Latin America Japanese Encephalitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Japanese Encephalitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Japanese Encephalitis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 94. Middle East and Africa Japanese Encephalitis Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 95. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Japanese Encephalitis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 98. Middle East and Africa Japanese Encephalitis Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 99. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 102. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 103. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Sanofi Pasteur Corporation Information
    Table 106. Sanofi Pasteur Description and Major Businesses
    Table 107. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 108. Sanofi Pasteur Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Sanofi Pasteur Recent Developments
    Table 110. GlaxoSmithKline Corporation Information
    Table 111. GlaxoSmithKline Description and Major Businesses
    Table 112. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 113. GlaxoSmithKline Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GlaxoSmithKline Recent Developments
    Table 115. Bharat Biotech Corporation Information
    Table 116. Bharat Biotech Description and Major Businesses
    Table 117. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 118. Bharat Biotech Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bharat Biotech Recent Developments
    Table 120. China National Biotec Group Corporation Information
    Table 121. China National Biotec Group Description and Major Businesses
    Table 122. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 123. China National Biotec Group Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. China National Biotec Group Recent Developments
    Table 125. Valneva Products Corporation Information
    Table 126. Valneva Products Description and Major Businesses
    Table 127. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 128. Valneva Products Japanese Encephalitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Valneva Products Recent Developments
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Japanese Encephalitis Vaccines Distributors List
    Table 133. Japanese Encephalitis Vaccines Customers List
    Table 134. Japanese Encephalitis Vaccines Market Trends
    Table 135. Japanese Encephalitis Vaccines Market Drivers
    Table 136. Japanese Encephalitis Vaccines Market Challenges
    Table 137. Japanese Encephalitis Vaccines Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Japanese Encephalitis Vaccines Product Picture
    Figure 3. Global Japanese Encephalitis Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Attenuated Vaccines Product Picture
    Figure 4. Inactivated Vaccines Product Picture
    Figure 5. Global Japanese Encephalitis Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Adults
    Figure 7. Children
    Figure 8. Japanese Encephalitis Vaccines Report Years Considered
    Figure 9. Global Japanese Encephalitis Vaccines Sales 2017-2028 (K Doses)
    Figure 10. Global Japanese Encephalitis Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Japanese Encephalitis Vaccines Revenue 2017-2028 (US$ Million)
    Figure 12. Global Japanese Encephalitis Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2017-2022)
    Figure 14. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2023-2028)
    Figure 15. North America Japanese Encephalitis Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 16. North America Japanese Encephalitis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Japanese Encephalitis Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 18. Europe Japanese Encephalitis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Japanese Encephalitis Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 20. Asia-Pacific Japanese Encephalitis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Japanese Encephalitis Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 22. Latin America Japanese Encephalitis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Japanese Encephalitis Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 24. Middle East & Africa Japanese Encephalitis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Japanese Encephalitis Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Japanese Encephalitis Vaccines in the World: Market Share by Japanese Encephalitis Vaccines Revenue in 2021
    Figure 27. Global Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
    Figure 29. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 30. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
    Figure 31. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 32. North America Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
    Figure 33. North America Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 34. North America Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
    Figure 35. North America Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 36. North America Japanese Encephalitis Vaccines Sales Share by Country (2017-2028)
    Figure 37. North America Japanese Encephalitis Vaccines Revenue Share by Country (2017-2028)
    Figure 38. U.S. Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
    Figure 41. Europe Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
    Figure 43. Europe Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Japanese Encephalitis Vaccines Sales Share by Country (2017-2028)
    Figure 45. Europe Japanese Encephalitis Vaccines Revenue Share by Country (2017-2028)
    Figure 46. Germany Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 47. France Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Japanese Encephalitis Vaccines Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Japanese Encephalitis Vaccines Revenue Share by Region (2017-2028)
    Figure 57. China Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. India Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Japanese Encephalitis Vaccines Sales Share by Country (2017-2028)
    Figure 72. Latin America Japanese Encephalitis Vaccines Revenue Share by Country (2017-2028)
    Figure 73. Mexico Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Japanese Encephalitis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Japanese Encephalitis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Japanese Encephalitis Vaccines Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Japanese Encephalitis Vaccines Revenue Share by Country (2017-2028)
    Figure 82. Turkey Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Japanese Encephalitis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. Japanese Encephalitis Vaccines Value Chain
    Figure 86. Japanese Encephalitis Vaccines Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
  1. Global Market, By Product Types, 2018-2028 (USD Million)
  2. Global Market, By Applications, 2018-2028 (USD Million)
  3. Global Secure Messaging, Japanese Encephalitis Vaccines Market, By Region, 2018-2028 (USD Million)
  4. Global Web Portal, Japanese Encephalitis Vaccines Market, By Region, 2018-2028 (USD Million)
  5. Global Private, Japanese Encephalitis Vaccines Market, By Region, 2018-2028 (USD Million)
  6. Global Public,Japanese Encephalitis Vaccines Market, By Region, 2018-2028 (USD Million)
  7. North America Market, By Product Types, 2018-2028 (USD Million)
  8. North America Market, By Applications, 2018-2028 (USD Million)
  9. U.S. Market, By Product Types, 2018-2028 (USD Million)
  10. U.S. Market, By Applications, 2018-2028 (USD Million)
  11. Canada Market, By Product Types, 2018-2028 (USD Million)
  12. Canada Market, By Applications, 2018-2028 (USD Million)
  13. Mexico Market, By Product Types, 2018-2028 (USD Million)
  14. Mexico Market, By Applications, 2018-2028 (USD Million)
  15. Europe Market, By Product Types, 2018-2028 (USD Million)
  16. Europe Market, By Applications, 2018-2028 (USD Million)
  17. U.K. Market, By Product Types, 2018-2028 (USD Million)
  18. U.K. Market, By Applications, 2018-2028 (USD Million)
  19. Germany Market, By Product Types, 2018-2028 (USD Million)
  20. Germany Market, By Applications, 2018-2028 (USD Million)
  21. Italy Market, By Product Types, 2018-2028 (USD Million)
  22. Italy Market, By Applications, 2018-2028 (USD Million)
  23. France Market, By Product Types, 2018-2028 (USD Million)
  24. France Market, By Applications, 2018-2028 (USD Million)
  25. Russia Market, By Product Types, 2018-2028 (USD Million)
  26. Russia Market, By Applications, 2018-2028 (USD Million)
  27. Asia-Pacific Market, By Product Types, 2018-2028 (USD Million)
  28. Asia-Pacific Market, By Applications, 2018-2028 (USD Million)
  29. India Market, By Product Types, 2018-2028 (USD Million)
  30. India Market, By Applications, 2018-2028 (USD Million)
  31. Japan Market, By Product Types, 2018-2028 (USD Million)
  32. Japan Market, By Applications, 2018-2028 (USD Million)
  33. China Market, By Product Types, 2018-2028 (USD Million)
  34. China Market, By Applications, 2018-2028 (USD Million)
  35. South Korea Market, By Product Types, 2018-2028 (USD Million)
  36. South Korea Market, By Applications, 2018-2028 (USD Million)
  37. Australia Market, By Product Types, 2018-2028 (USD Million)
  38. Australia Market, By Applications, 2018-2028 (USD Million)
  39. Latin America Market, By Product Types, 2018-2028 (USD Million)
  40. Latin America Market, By Applications, 2018-2028 (USD Million)
  41. Brazil Market, By Product Types, 2018-2028 (USD Million)
  42. Brazil Market, By Applications, 2018-2028 (USD Million)
  43. Middle East & Africa Market, By Product Types, 2018-2028 (USD Million)
  44. Middle East & Africa Market, By Applications, 2018-2028 (USD Million)
  45. Saudi Arabia Market, By Product Types, 2018-2028 (USD Million)
  46. Saudi Arabia Market, By Applications, 2018-2028 (USD Million)
  47. UAE Market, By Product Types, 2018-2028 (USD Million)
  48. UAE Market, By Applications, 2018-2028 (USD Million)
  49. South Africa Market, By Product Types, 2018-2028 (USD Million)
  50. South Africa Market, By Applications, 2018-2028 (USD Million)
  1. Global Japanese Encephalitis Vaccines Market Segmentation
  2. Global Japanese Encephalitis Vaccines Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Global Market Attractiveness Analysis By Product Types
  9. Global Market Attractiveness Analysis By Applications
  10. Global Japanese Encephalitis Vaccines Market Attractiveness Analysis ByRegion
  11. Global Japanese Encephalitis Vaccines Market: Dynamics
  12. Global Market Share By Product Types (2021 & 2028)
  13. Global Market Share By Applications (2021 & 2028)
  14. Global Japanese Encephalitis Vaccines Market Share By Region (2021 & 2028)
  15. Global Japanese Encephalitis Vaccines Market Share By Company (2020)
We Accept
Select License
Includes
  • Purchase Report Sections
  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Latest Reports